View Post

Optiscan Imaging (ASX:OIL) begins stage three of breast cancer study

In Clinical Trials by Barbara Jacoby

By: Julia Seymour From: Optiscan Imaging (OIL) has begun stage three of its breast cancer study in Melbourne. The study will involve 20 breast cancer patients at Royal Melbourne Hospital, Frances Perry House and Epworth Hospital using Optiscan’s FIVE2/Viewnvivo endomicroscope. The Optiscan endomicroscope enables real-time, 3D, ‘in vivo’ imaging of human tissue at the cellular level, providing instant virtual …